Technical Analysis for DOVA - Dova Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 8.8 -6.08% -0.57
DOVA closed down 6.08 percent on Friday, March 22, 2019, on 1.19 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical DOVA trend table...

Date Alert Name Type % Chg
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 21 Narrow Range Bar Range Contraction -6.08%
Mar 21 Inside Day Range Contraction -6.08%
Mar 21 Wide Bands Range Expansion -6.08%
Mar 21 Overbought Stochastic Strength -6.08%
Mar 21 Up 3 Days in a Row Strength -6.08%
Mar 21 Up 4 Days in a Row Strength -6.08%
Mar 21 Up 5 Days in a Row Strength -6.08%
Mar 20 Calm After Storm Range Contraction -5.78%

Older signals for DOVA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocytopenia in patients with chronic liver disease (CLD). The Company’s product candidate, avatrombopag is an orally administered thrombopoietin receptor agonist, or TPO-RA. The Company has completed pivotal Phase 3 clinical trials that evaluated avatrombopag for the treatment of thrombocytopenia in patients with CLD. The Company has not generated any revenue.
Medicine Pharmaceutical Blood Orphan Drugs Disorder Platelet Hematopathology Immune Thrombocytopenic Purpura Thrombocytopenia Thrombopoietin Receptor Agonists
Is DOVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 35.33
52 Week Low 5.62
Average Volume 181,608
200-Day Moving Average 17.5564
50-Day Moving Average 7.9962
20-Day Moving Average 8.3245
10-Day Moving Average 8.939
Average True Range 0.5666
ADX 28.71
+DI 29.2746
-DI 15.4416
Chandelier Exit (Long, 3 ATRs ) 7.940200000000001
Chandelier Exit (Short, 3 ATRs ) 8.6717
Upper Bollinger Band 9.7454
Lower Bollinger Band 6.9036
Percent B (%b) 0.67
BandWidth 34.137786
MACD Line 0.3198
MACD Signal Line 0.2017
MACD Histogram 0.1181
Fundamentals Value
Market Cap 225.74 Million
Num Shares 25.7 Million
EPS -2.09
Price-to-Earnings (P/E) Ratio -4.21
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.85
Resistance 3 (R3) 9.95 9.71 9.68
Resistance 2 (R2) 9.71 9.44 9.66 9.62
Resistance 1 (R1) 9.25 9.27 9.13 9.15 9.56
Pivot Point 9.01 9.01 8.95 8.96 9.01
Support 1 (S1) 8.55 8.74 8.43 8.45 8.04
Support 2 (S2) 8.31 8.57 8.26 7.98
Support 3 (S3) 7.85 8.31 7.93
Support 4 (S4) 7.75